RNA-seq: a complete guide

1. Introduction

RNA sequencing (RNA-seq) is a high-throughput technology used to determine RNA sequences from any type of sample and quantify the relative abundance of unique RNA sequences in a population. Unlike older microarray-based methods, RNA-seq provides a comprehensive and unbiased view of the transcriptome, revealing key insights into e.g gene expression, mRNA splicing, non-coding RNA regulation, and enhancer RNA activity. Nearly 100 distinct RNA-seq methods have emerged, driven by advancements in experimental and computational approaches 1.
RNA-seq is used in disease research, diagnostics, and medication development. It improves public health surveillance and the detection of diseases such as HIV and SARS-CoV-2 by tracking real-time viral strains2. In Mendelian illnesses, RNA-seq plus genomics boosts the diagnosis rates by 15% as it finds causal variations and provides functional molecular evidence. In oncology research, it contributes to discovering biomarkers, analyzing tumor heterogeneity, and resolving drug resistance and immunotherapy challenges. Moreover, its ability to profile dynamic transcriptomes enables the development of tailored medicines with fewer side effects 3.
With all the different techniques available, it can be difficult to know which technique is applicable for which use.

Total RNA-Seq:

2. RNA-Seq Techniques

mRNA SEQUENCING

The technique focuses on messenger RNA, which is the central molecule for protein synthesis. Thus, it allows one to investigate active gene expression and gene translation under various conditions. The technique is used in illness models for alterations in gene expression, identifying therapeutic targets for drug development, and testing drugs to evaluate the treatment effects on the activity of genes. For example, mRNA-Seq is essential to understand how cancerous cells respond to drugs and provides the vital information during the drug development process.

Total RNA sequencing

Total RNA-Seq collects all types of RNA, i.e., mRNA, rRNA, and tRNA. This technique provides a complete view of the transcriptome, which is very important in the study of non-coding RNAs and changes in RNA. This method makes use of Total RNA-Seq in the study of regulatory RNAs that regulate gene expression and cellular processes without encoding proteins. The choice between mRNA-Seq and total RNA sequencing depends on the study’s objectives. mRNA-Seq is used for genes in treatments or diseases, while total RNA sequencing is suitable for studying RNA species’ complexity in multicellular systems. Both require advanced bioinformatic analysis for interpretation4.
Recent developments allow working with challenging samples, like degraded RNA, FFPE or single cells. With these advancements, low-quality RNA can be useful by stepwise mapping, and in single-cell cancer studies “RAG-seq” and “snHH-seq” enhance the sensitivity. Automated platforms provide large-scale analyses to make it easier for researchers to determine the complexity of the transcriptome and therapeutic targets 4,5,6.

Poly(A) RNA Seq

Poly(A) RNA sequencing targets RNAs with poly(A) tails. These include mRNAs and lncRNAs. This technology relies on the stability and relevance of poly(A) tails for the 3′ ends of eukaryotic mRNAs. It strengthens RNA stability, protects from degradation, helps in exporting mRNA and facilitates its translation. Poly(A) RNA-seq will uncover the complexity of a transcriptome, levels of gene expression, and alternative splicing events. It is useful for the discovery of splice variants and for post-transcriptional regulation and characterization of the isoforms. Since it does not recover degraded mRNAs or non-poly(A) transcripts, it may introduce noise and selection bias in gene expression analysis. The preparation of libraries for poly(A) RNA-seq involves enrichment of mRNA from total RNA, which focuses on poly(A)+ transcripts. This makes poly(A) RNA-seq a reliable technique to study protein-coding genes and their regulatory mechanisms though excluding non-poly(A) RNAs 7.

3’ UTR mRNA sequencing

3′ UTR mRNA sequencing, commonly known as 3′ mRNA-seq, is a specialized approach that focuses on the 3′ untranslated region of polyadenylated RNA molecules. It enables efficient and reliable assessment of gene expression with fewer reads per sample, decreasing the costs of sequencing but keeping substantial transcriptome-wide insights equivalent to full-length RNA-seq approaches. It is notably valuable for examining processes of regulation involving the 3′ UTR, including alternative polyadenylation, a fundamental method of gene expression regulation. Researchers have mapped 3′ UTR diversity over a wide range of different samples ranging from C. elegans to human tumor types. Despite the high-quality curated 3′ UTR resources supplied by databases such as UTRdb and Ensembl, comparative genome-wide research outside model organisms remains challenging due to the poor annotations 8.

Bulk RNA Barcoding and Sequencing

Bulk RNA barcoding and sequencing (BRB-seq) is cost-effective for the high throughput of transcriptomics. It provides affordability comparable to single-cell RNA sequencing plus the traditional efficiency in bulk RNA sequencing. BRB-seq consequently provides extremely high-quality libraries that are just as good as those generated by technologies like TruSeq; a reproducible and inexpensive option for RNA-seq. This method is important for discovering molecular pathways of health and illness. These enable versatility for researching homogeneous cell groupings and can easily face tough sample preparations or budget restrictions. Additionally, computational approaches can improve bulk RNA-seq data by assessing cell-type diversity. These applications make BRB-seq a cheap, scalable, and reliable approach for transcriptome studies and give complementary utility to newer technologies 9.

Small RNA Sequencing

Small RNA sequencing (Seq) is a technique that has high sensitivity and dynamic range to isolate and sequence small RNA molecules, including microRNAs (miRNAs). It allows for the genome-wide profiling of known and novel miRNA variants, which gives deep insights into the small RNA transcriptome. However, it is also subject to technical bias and incomplete miRNA representation, limiting its full potential. These biases have been reduced and the technique is proving to be effective and comprehensive technology. It first appeared in 2005 and later on it was mostly used with more than 700 human miRNA profiles deposited in GEO 10.

4. Choosing the Right RNA-Seq Technique

The choice of the appropriate approach to RNA-Seq is a prerequisite for achieving success and depends on depth of analysis, RNA type, and complexity in the transcriptome. Total RNA-Seq is the most comprehensive technique as it covers both coding and non-coding RNAs. This is highly ideal for studying complex transcriptomes, regulatory processes, and alternative splicing patterns. In contrast, mRNA-Seq targets polyadenylated mRNA and is, therefore, the optimal choice for gene expression study, especially in cases of constrained resources such as sample size or budget. Specialized studies might make use of small RNA-Seq on short regulatory RNAs, whereas technologies such as ribosomal RNA depletion enhance data quality. Researchers must consider the nature of their samples, sequencing depth and cost to match their choice with experimental goals. Balancing these factors will ensure accurate, efficient and useful insights for a range of RNA-based studies 4,10.

5. Conclusion

RNA sequencing has revolutionized the understanding of the transcriptome, providing insights into gene expression, regulatory mechanisms, and RNA diversity. Tailoring RNA-Seq techniques to specific research goals in coding RNAs, non-coding RNAs, or small RNA populations may unlock meaningful discoveries across a wide range of applications, from disease diagnostics to therapeutic development. Advancements in technology allow for further insights through innovative long-read sequencing processes. Aligning research goals with the right sequencing strategies can provide cost-effective studies and impact scientific discovery. Researchers, biotech professionals, and labs continue advancing basic biology and precision medicine by recognizing and harnessing strengths within RNA-Seq. As RNA-seq methods are maturing, their introduction into clinical studies has expanded drastically over the last years.

References

[1] Deshpande, D., Chhugani, K., Chang, Y., Karlsberg, A., Loeffler, C., Zhang, J., … & Mangul, S. (2023). RNA-seq data science: From raw data to effective interpretation. Frontiers in Genetics, 14, 997383.
[2] Louis, I. V. S., Gorzalski, A., & Pandori, M. (2021). Diagnostic applications for RNA-Seq technology and transcriptome analyses in human diseases caused by RNA viruses. Applications of RNA-Seq in Biology and Medicine, 122-138.
[3] Hong, M., Tao, S., Zhang, L., Diao, L. T., Huang, X., Huang, S., … & Zhang, H. (2020). RNA sequencing: new technologies and applications in cancer research. Journal of hematology & oncology, 13, 1-16.
[5] Xu, P., Yuan, Z., Lu, X., Zhou, P., Qiu, D., Qiao, Z., … & Yu, Y. (2024). RAG-seq: A NSR Primed and Transposase Tagmentation Mediated Strand-specific Total RNA Sequencing in Single Cell. Genomics, Proteomics & Bioinformatics, qzae072.
[6] Chen, H., Fang, X., Shao, J., Zhang, Q., Xu, L., Chen, J., … & Guo, G. (2024). Pan‐Cancer Single‐Nucleus Total RNA Sequencing Using snHH‐Advanced Science, 11(5), 2304755.
[7] Yu, F., Zhang, Y., Cheng, C., Wang, W., Zhou, Z., Rang, W., … & Zhang, Y. (2020). Poly (A)-seq: A method for direct sequencing and analysis of the transcriptomic poly (A)-tails. PloS one, 15(6), e0234696.
[8] Huang, Z., & Teeling, E. C. (2017). ExUTR: a novel pipeline for large-scale prediction of 3′-UTR sequences from NGS data.BMC genomics, 18, 1-11.
[9] Janjic, A., Wange, L. E., Bagnoli, J. W., Geuder, J., Nguyen, P., Richter, D., … & Enard, W. (2022). Prime-seq, efficient and powerful bulk RNA sequencing. Genome biology, 23(1), 88.
[10] Benesova, S., Kubista, M., & Valihrach, L. (2021). Small RNA-sequencing: approaches and considerations for miRNA analysis. Diagnostics, 11(6), 964.

Search all posts

Popular news & events

Tags

Do you have questions about RNA sequencing?

Fill out the form below and our experts will get back to you as soon as possible!
Logo-OHMX.bio
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Cookie statement

Last updated:  19-09-2024

This cookie statement is drafted and managed by OHMX.bio NV,

hereafter referred to as “OHMX.bio”.

OHMX.bio has its headquarters at Proeftuinstraat 86, 9000 Gent, Belgium, registered with company number XXX.

For all questions and/or remarks, please contact us at the address mentioned above or at the e-mail address privacy@ohmx.bio.

USE OF COOKIES

 

OHMX.bio considers it important that you can view, listen to, read or experience our website content at any place and at any time via various media platforms. We want you to be able to use interactive features and provide services tailored to your needs. Therefore OHMX.BIO uses online techniques like cookies, scripts and similar technologies (hereafter referred to as ‘cookies’). These help us facilitate the use of the website and improve its functionality, by collecting (personal) data of our website visitors via their website usage.

 

In this cookie statement, OHMX.bio wishes to inform you what kind of cookies are used and why.

OHMX.bio can amend the cookie statement at any time. This can happen, for example, in the context of changes to its services or the applicable legislation. The amended statement will then be published on the OHMX.bio websites and will apply from the moment it is published.

 

If the use of certain cookies also involves the processing of “personal data”, the OHMX.bio Privacy Statement is also applicable.

 

WHAT ARE COOKIES?

 

A cookie is a small data file that is installed in the browser of your computer or mobile device by a website's server or application when you visit a website or use a (mobile) application.

The cookie file contains a unique code with which your browser can be recognized during the visit to the online service or during consecutive, repeated visits. They generally make the interaction between the visitor and the website or application easier and faster and help the visitor to navigate between the different parts of a website or application. They allow us to retain certain settings, such as your language choice or to optimize your user experience.

 

There are different types of cookies that can be distinguished according to their origin, function and lifespan. This is explained further in the next section.

TYPES OF COOKIES

How long are cookies stored?

Cookies can be stored on your computer or mobile device for different periods of time. Depending on the type, they (and the information they collect) are automatically deleted when you close your browser (these are the so-called “session cookies”), in other cases, these remain stored for a longer period of time and can also be used during a subsequent visit to this website (these are the so-called “permanent cookies”).

Consult the detailed information on OHMX.bio cookies (below) to know the retention periods.

Who places and manages cookies?

First-party cookies

First-party cookies are managed by OHMX.bio and are specific to the visited or used online service.

Third party cookies

Third party cookies are managed and placed by a third party. This happens during your visit or use of the website. These ensure that certain information is sent to third parties by your visit to the website.

Why cookies?

Necessary cookies

Necessary or essential cookies are necessary for the operation of the website. It is therefore advised not to disable these.

Functional cookies

These are cookies that ensure that the website functions properly. Examples of some functions performed:

- remembering your login details

- ensuring the security of your login details

- ensuring the uniformity of the layout of the website

Performance and analysis cookies

On the basis of these cookies, information is collected about the way visitors use our website. This is done with the intention to improve the content of our websites, to further adapt it to the wishes of the visitors and to increase the usability of our websites. Like for example google analytics.

Social media cookies

The website can implement so-called embedded elements of other third parties, such as YouTube, Twitter and Facebook. These are used to integrate social media into the website via plug-ins.

Other cookies

These are cookies that do not belong to one of the above categories. For example, cookies that can be used to make web analyzes themselves to optimize the website. In addition to the above-mentioned performance and analysis cookies, other web analysis cookies can be used. These will probably have to be disabled because identifiable personal data may be processed here. This is not the case with the mentioned performance analysis cookies.

OHMX.bio  uses different types of cookies.

 

Cookie Description Duration Type
cookielawinfo-checkbox-necessary This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". 1 hour Necessary
__utma This cookie is set by Google Analytics and is used to distinguish users and sessions. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 2 years Performance
__utmc The cookie is set by Google Analytics and is deleted when the user closes the browser. The cookie is not used by ga.js. The cookie is used to enable interoperability with urchin.js which is an older version of Google analytics and used in conjunction with the __utmb cookie to determine new sessions/visits. Performance
__utmz This cookie is set by Google analytics and is used to store the traffic source or campaign through which the visitor reached your site. 5 months Performance
__utmt The cookie is set by Google Analytics and is used to throttle request rate. 10 minutes Performance
__utmb The cookie is set by Google Analytics. The cookie is used to determine new sessions/visits. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 30 minutes Performance

 

HOW CAN YOU TURN OFF COOKIES?

 

If you choose to disable cookies, you can do so for the browser you use:

 

If you use different devices to visit this website, make sure that your cookie preferences are set on the browser of every device.

 

Please note that disabling certain cookies may result in the malfunction of related features on the website e.g. certain graphics may not show the way they are meant to, or you may not be able to use certain services.

CHANGES TO THIS COOKIE STATEMENT

OHMX.BIO may amend this Cookie Statement in accordance with certain technical, legal or commercial requirements and developments. We will inform you accordingly, taking into account the importance of the changes that have been made. You may find the date on which this Cookie Statement was last modified at the top of this Cookie Statement.